Management ChangeJun 5, 2026, 04:37 PM
Indaptus: Two Directors & COO Resign; COO Becomes Consultant
AI Summary
Indaptus Therapeutics announced the resignations of two directors, Mr. David E. Lazar and Mr. Avraham Ben-Tzvi, from all directorship positions, effective June 5, 2026. Additionally, Mr. Walt A. Linscott, Esq. resigned as Chief Operating Officer, effective June 1, 2026, but will transition to a consulting role for the Company. The Company stated that these resignations were not due to any disagreements regarding its operations, policies, or practices.
Key Highlights
- David E. Lazar resigned from all directorship positions on the Board of Indaptus Therapeutics, effective June 5, 2026.
- Avraham Ben-Tzvi resigned from all directorship positions on the Board, effective June 5, 2026.
- Walt A. Linscott, Esq. resigned as Chief Operating Officer, effective June 1, 2026.
- Mr. Linscott will continue to serve as a consultant for the Company under a new agreement dated June 1, 2026.
- The resignations were not a result of any disagreement with the Company's operations, policies, or practices.
Price Impact
More from INDP